Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METAL-HCM: Perhexiline in Hypertrophic Cardiomyopathy
NCT00500552Phase 2Completed
- Sponsor
- University Hospitals Birmingham
- Start
- Dec 2006
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of perhexiline in hypertrophic cardiomyopathy (HCM), sponsored by University Hospitals Birmingham. Started Dec 2006; status: completed.
02
Drugs
perhexiline
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT00500552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00500552.